Categories
October Surprise 2024

INOmaxĀ® – Mallinckrodt Pharmaceuticals

INOmax Ā® (inhaled nitric oxide) is indicated for the treatment of term and late pre-term (≄ 34 weeks) neonates with hypoxic respiratory failure associated with pulmonary hypertension. Please consult the product monograph below for contraindications, warnings, precautions, adverse reactions, interactions, and conditions of clinical use. The product monograph is also available by calling us …